Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

4.265 +0.045 (+1.07%)
Delayed Quote Updated: 12:19 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanda Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Why Is Trilogy Metals (TMQ) Stock Down 29% Today? ↗
Trilogy Metals stock is falling on Wednesday as TMQ investors react to reports that the government plans to block its Ambler Access Project. 
Via InvestorPlace
News headline image
Why Is Vanda Pharmaceuticals (VNDA) Stock Up 34% Today? ↗
Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their shares. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday! 
Via InvestorPlace
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Near the Top of Equities by Percentage Gain on 4/3
Via Investor Brand Network
News headline image
Vanda Pharma: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 7, 2024 ↗
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
News headline image
Earnings Preview For Vanda Pharma ↗
 
Via Benzinga
News headline image
Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings ↗
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up 0.08% to 39,200.08 while the NASDAQ rose 0.46% to 16,315.68. The S&P 500 also... 
Via Benzinga
Topics Stocks
News headline image
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly... 
Via Benzinga
News headline image
Vanda Pharma: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Outlook For Vanda Pharma ↗
 
Via Benzinga
News headline image
Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday ↗
The pharmaceutical company's stock hit another 52-week low. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Moves Higher; ISM Services PMI Falls In March ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 0.5% on Wednesday. The Dow traded up 0.18% to 39,241.00 while the NASDAQ rose 0.55% to 16,329.45. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
EDR Stock Alert: Endeavor Group Is Going Private for $13 Billion ↗
Endeavor Group stock is on the move Wednesday as EDR holders react to news of Silver Lake taking the sports and entertainment company private. 
Via InvestorPlace
News headline image
Costco Weight Loss Program: How You Can Get Ozempic From Costco ↗
Costco is offering a new weight loss program for subscribers that may also include prescriptions for weight loss drug Ozempic. 
Via InvestorPlace
News headline image
Why Is Vanda Pharmaceuticals (VNDA) Stock Up 33% Today? ↗
Vanda Pharmaceuticals stock is rising higher on Wednesday as investors in VNDA celebrate FDA approval of its bipolar treatment. 
Via InvestorPlace
News headline image
Why Is Vanda Pharmaceuticals Stock Trading Higher Today? ↗
FDA approves Vanda Pharmaceuticals' Fanapt tablets for bipolar I disorder manic or mixed episodes in adults. Fanapt, an atypical antipsychotic, shows significant improvement over placebo in pivotal... 
Via Benzinga
News headline image
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a hot topic this morning as we check out all of the biggest news worth reading about on Wednesday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company ↗
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Vanda Pharmaceuticals: A Beautiful Head And Shoulders Top ↗
I wanted to share this chart of Vanda Pharmaceuticals​​​​ since it is sporting such a beautiful head and shoulders top 
Via Talk Markets
News headline image
Earnings Scheduled For November 8, 2023 ↗
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday morning, 164 companies achieved new lows for the year. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.